Related Experiment Video
Updated: Apr 10, 2026

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Placental pathologic changes in gestational diabetes mellitus.
Patrycja Jarmuzek1, Miroslaw Wielgos1, Dorota Bomba-Opon1
11st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.
Maternal obesity increases gestational diabetes mellitus (GDM) risk, impacting fetal health. GDM alters placental development and function, potentially causing adverse pregnancy outcomes due to maternal-placental-fetal interface dysfunction.
Area of Science:
- Obstetrics and Gynecology
- Perinatology
- Endocrinology
Background:
- Rising maternal obesity rates correlate with increased gestational diabetes mellitus (GDM) incidence.
- GDM is linked to adverse fetal and neonatal outcomes, including macrosomia and respiratory distress.
- The placenta plays a critical role in maternal-fetal interactions, particularly in GDM pregnancies.
Purpose of the Study:
- To review placental structural and functional changes in the context of abnormal glucose metabolism.
- To explore how hyperglycemia affects placental development and function.
- To understand the maternal-placental-fetal interface dysfunction in GDM.
Main Methods:
- Review of existing literature on placental changes in GDM.
- Analysis of histological findings in placentas from GDM pregnancies.
- Examination of the relationship between glycemic control timing and placental alterations.
Main Results:
- Placentas in GDM pregnancies exhibit altered development, vascular dysfunction, and histological changes like villous immaturity and increased angiogenesis.
- The timing of GDM diagnosis influences the type of placental dysfunction (structural vs. functional).
- Diabetic placental changes are associated with inflammation, oxidative stress, and potential chronic fetal hypoxia.
Conclusions:
- Hyperglycemia in GDM significantly impacts placental development, anatomy, and function.
- Placental dysfunction is a key factor in GDM-associated adverse pregnancy outcomes.
- Further research into the hyperglycemia-placental dysfunction-pregnancy complication pathway is warranted.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Teratogenicity
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

